| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CTRN | Common Stock, $0.01 par value | Other | $0 | -180K | -75.77% | $0.00 | 57.4K | Jan 6, 2022 | By Macellum SPV III, LP | F2, F3 |
| holding | CTRN | Common Stock, $0.01 par value | 8.29K | Jan 6, 2022 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Represents shares of restricted stock awarded to Mr. Duskin in his capacity as a director of the Issuer. The restricted stock will vest on the earlier of (i) one year after the date of grant, which would be June 16, 2022 or (ii) the date of the annual meeting of the Company's stockholders in 2022, provided Mr. Duskin is a director of the Issuer at such time. |
| F2 | Represents securities of the Issuer owned directly by Macellum SPV III, LP ("Macellum SPV"). Macellum Management, LP ("Macellum Management") serves as the investment manager of Macellum SPV. Macellum Advisors GP, LLC ("Macellum GP") serves as the general partner of Macellum Management and Macellum SPV. As the sole member of Macellum GP, Mr. Duskin may be deemed to beneficially own the securities of the Issuer owned directly by Macellum SPV. Mr. Duskin disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. |
| F3 | Represents a pro rata distribution from Macellum SPV to its investors for no consideration. |